Physician profile
Blair Barton
NPI 1033538061
$6,026.29
in general payments reported to CMS, 2019-2025
13 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $122 · 2022: $1,928 · 2023: $390 · 2024: $1,515 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,774 · Consulting Fee: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.10 |
| Consulting Fee | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,756.29 | 2020-2025 | Scopis Ent, Aero-Ll, Na |
| Medtronic, INC. | $1,603.63 | 2022-2025 | Propel, Stealthstation S8 Platform, Fusion |
| 3-D Matrix, INC. | $980.81 | 2024-2025 | |
| Integra Lifesciences Corporation | $498.02 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Acclarent, INC | $463.82 | 2021-2022 | |
| Regeneron Pharmaceuticals, INC. | $140.01 | 2025 | Dupixent |
| Regeneron Healthcare Solutions, INC. | $133.65 | 2023 | Dupixent |
| Organogenesis INC. | $130.43 | 2024-2025 | Puraply Wound Matrix |
| Genzyme Corporation | $125.52 | 2025 | |
| Aerin Medical INC. | $124.82 | 2023 | |
| Kerecis Limited | $29.17 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Inspire Medical Systems, INC. | $23.45 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $16.67 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blair Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.